期刊文献+

宫腔镜下宫腔粘连分离术联合大剂量雌激素在治疗中重度宫腔粘连中的临床效果观察

Clinical effect observation of hysteroscopic separation of transcervical resection of adhesions combined with high-dose of estrogen in the treatment of moderate and severe intrauterine adhesions
下载PDF
导出
摘要 目的分析宫腔镜下宫腔粘连分离术(TCRA)联合大剂量雌激素治疗中重度宫腔粘连的临床效果。方法选取76例中重度宫腔粘连患者为研究对象,依据随机数字表法分为小剂量组与大剂量组,各38例。小剂量组予以TCRA联合戊酸雌二醇片口服,1mg/次,1次/d;大剂量组予以TCRA联合戊酸雌二醇片口服,2mg/次,2次/d,持续干预3个月。术后3个月统一评价两组的临床疗效,术前及术后3个月评价两组的子宫形态(子宫体积)和子宫内膜厚度。结果大剂量组的总有效率高于小剂量组(P<0.05)。两组术前的子宫体积和子宫内膜厚度比较,差异无统计学意义(P>0.05)。两组术后3个月的子宫体积和子宫内膜厚度均增加(P<0.05);大剂量组术后3个月的子宫体积和子宫内膜厚度均高于小剂量组(P<0.05)。结论TCRA联合大剂量雌激素可以进一步提高中重度宫腔粘连的临床效果,改善子宫形态,促进子宫内膜的早期恢复。 Objective To analyze the clinical effect of hysteroscopic separation of transcervical resection of adhesions(TCRA)combined with high-dose estrogen in the treatment of moderate and severe intrauterine adhesions.Methods A total of 76 patients with moderate and severe intrauterine adhesions were selected as the study subjects,they were divided into the low-dose group and the high-dose group according to the random number table method,38 cases in the each group.The low-dose group was given TCRA combined with estradiol valerate orally,1 mg/time,once a day.The high-dose group was given TCRA combined with estradiol valerate orally,2 mg/time,twice a day,and the intervention lasted for three months.The clinical efficacy of the two groups was evaluated uniformly at 3 months after surgery,and the uterine morphology(uterine volume)and endometrial thickness of the two groups were evaluated before and 3 months after surgery.Results The total effective rate of the high-dose group was higher than that of the low-dose group(P<0.05).There were no statistical significances in the preoperative uterine volume and endometrial thickness between the two groups(P>0.05).At 3 months after operation,the uterine volume and endometrial thickness of the two groups increased(P<0.05),and the uterine volume and endometrial thickness of the high-dose group were higher than those of the low-dose group(P<0.05).Conclusion TCRA combined with high-dose estrogen can further improve the clinical effect of moderate and severe uterine adhesions,improve uterine morphology,and promote the early recovery of endometrium.
作者 史凯凯 Shi Kaikai(Department of Obstetrics and Gynecology,Liyang People's Hospital of Jiangsu Province,Changzhou 213300,China)
出处 《实用妇科内分泌电子杂志》 2023年第10期19-21,共3页 Electronic Journal of Practical Gynecological Endocrinology
关键词 宫腔镜 宫腔粘连分离术 宫腔粘连 大剂量雌激素 Hysteroscope Intrauterine adhesion separation Intrauterine adhesion High dose estrogen
  • 相关文献

二级参考文献68

  • 1翟维佳.宫腔粘连分离术治疗宫腔粘连的疗效及其预后相关因素分析[J].临床医学,2020,0(1):52-54. 被引量:12
  • 2Taylor RN, Leboric DI, Hornung D, et al. Endocrine and paracrine regulation if endometrial angiogenesis, Ann N Y Acad Sci,2000,943: 109-121.
  • 3Macpherson AM, Archer DF, Leslies, et al. The effect of etonogestrel on VEGF,oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium, Hum Reprod, 1999,14 : 3080-3087.
  • 4Krussel JS,Behr B, Milki AA,et al. Vascular endothelial growth factor (VEGF)mRNA splice variants are differentially expressed in human blastocysts. Mol Hum Reprod, 2001,7(1) :57-63.
  • 5Rosalyn D, Blumenthal, Alice P, et al. Abnormal expression of the Angiopoietins and Tie receptors in menorrhagic endometrium. Obstet & Gynecol Survey, 2003,58(5) :321-322.
  • 6J. Mclaren. Vascular endothelial growth factor and endometriotic angiogenesis. H um Reprod Update, 2000,6 ( 1 ) :44-55.
  • 7M. Hickey,G. Pillai,J. M. Higham, et al. Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding. Humen Reproduction, 2003, 18 ( 5 ) : 1100-1106.
  • 8Osteen KG, Yeaman GR, Bruner T, et al. Matrix metalloproteinases and endometriosis. Semin Reprod Med,2003,21:155-164.
  • 9Lamoreaux WJ, Fitzgerald ME, Reiner A,et al. Vascular endothelial growth factor increases release of gelatinase A and decreases releases of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro.Microvasc Res, 1995,55( 1 ) : 29-42.
  • 10March CM. Management of Asherman Reprod Biomed Online, 2011,23 : 63 76. March CM. Asherman's syndrome[J]. 2011,29 : 83-94.

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部